-
1دورية أكاديمية
المؤلفون: Matera MG; Unit of Pharmacology, Department of Experimental Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy., Calzetta L; Unit of Respiratory Diseases and Lung Function, Department of Medicine and Surgery, University of Parma, Parma, Italy., Rinaldi B; Unit of Pharmacology, Department of Experimental Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy., Cazzola M; Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy., Rogliani P; Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.
المصدر: Expert opinion on drug delivery [Expert Opin Drug Deliv] 2023 Jul-Dec; Vol. 20 (8), pp. 1085-1095. Date of Electronic Publication: 2023 Sep 16.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 101228421 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7593 (Electronic) Linking ISSN: 17425247 NLM ISO Abbreviation: Expert Opin Drug Deliv Subsets: MEDLINE
-
2دورية أكاديميةTargeting the undruggable: emerging technologies in antibody delivery against intracellular targets.
المؤلفون: Niamsuphap S; ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland , Brisbane, Australia., Fercher C; ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland , Brisbane, Australia.; ARC Centre of Excellence in Convergent BioNano Science and Technology, AIBN, University of Queensland , Brisbane, Australia., Kumble S; ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland , Brisbane, Australia., Huda P; ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland , Brisbane, Australia.; Centre for Advanced Imaging (CAI), University of Queensland , Brisbane, Australia., Mahler SM; ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland , Brisbane, Australia., Howard CB; ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland , Brisbane, Australia.; Centre for Personalised Nanomedicine, AIBN, University of Queensland , Brisbane, Australia.
المصدر: Expert opinion on drug delivery [Expert Opin Drug Deliv] 2020 Sep; Vol. 17 (9), pp. 1189-1211. Date of Electronic Publication: 2020 Aug 13.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review
بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 101228421 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7593 (Electronic) Linking ISSN: 17425247 NLM ISO Abbreviation: Expert Opin Drug Deliv Subsets: MEDLINE
-
3دورية أكاديمية
المؤلفون: Jin Z; Department of Neurosurgery, The First Hospital of Jilin University, Changchun, PR China., Piao L; Department of Physiology, College of Basic Medical Sciences, Jilin University, Changchun, PR China., Sun G; Department of Neurosurgery, The First Hospital of Jilin University, Changchun, PR China., Lv C; Department of Neurosurgery, The First Hospital of Jilin University, Changchun, PR China., Jing Y; Department of Neurosurgery, The First Hospital of Jilin University, Changchun, PR China., Jin R; Department of Neurosurgery, The First Hospital of Jilin University, Changchun, PR China.
المصدر: Journal of drug targeting [J Drug Target] 2021 Mar; Vol. 29 (3), pp. 323-335. Date of Electronic Publication: 2020 Nov 16.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312476 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2330 (Electronic) Linking ISSN: 10267158 NLM ISO Abbreviation: J Drug Target Subsets: MEDLINE
مواضيع طبية MeSH: Nanoparticles*, Antibodies, Monoclonal/*administration & dosage , Brain Neoplasms/*drug therapy , Glioblastoma/*drug therapy, Animals ; Antibodies, Monoclonal/pharmacokinetics ; Antibodies, Monoclonal/pharmacology ; Blood-Brain Barrier/metabolism ; Brain Neoplasms/immunology ; Cell Line, Tumor ; Dendrimers/chemistry ; Drug Delivery Systems ; Glioblastoma/immunology ; Humans ; Immune Checkpoint Inhibitors/administration & dosage ; Immune Checkpoint Inhibitors/pharmacokinetics ; Immune Checkpoint Inhibitors/pharmacology ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; NK Cell Lectin-Like Receptor Subfamily C/immunology ; Phosphatidylinositol 3-Kinase/metabolism ; RNA, Long Noncoding/genetics ; RNA, Small Interfering/administration & dosage ; Tumor Microenvironment/immunology
-
4دورية أكاديمية
المؤلفون: Davis KL; a Bass Center for Childhood Cancer and Blood Disorders, Department of Pediatrics , Stanford University School of Medicine , Palo Alto , California., Agarwal AM; b Department of Pathology , University of Utah and ARUP Laboratories , Salt Lake City, Utah., Verma AR; c Primary Children's Hospital, Pediatric Hematology Oncology, Department of Pediatrics , University of Utah , Salt Lake City, Utah.
المصدر: Pediatric hematology and oncology [Pediatr Hematol Oncol] 2017 Sep - Oct; Vol. 34 (6-7), pp. 379-394. Date of Electronic Publication: 2017 Nov 30.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8700164 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0669 (Electronic) Linking ISSN: 08880018 NLM ISO Abbreviation: Pediatr Hematol Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Cell Cycle Checkpoints* , Drug Delivery Systems* , Hematologic Neoplasms*/drug therapy , Hematologic Neoplasms*/metabolism , Hematologic Neoplasms*/pathology , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/metabolism , Leukemia, Myeloid, Acute*/pathology, Antibodies, Monoclonal/*therapeutic use , B7-H1 Antigen/*antagonists & inhibitors , Ipilimumab/*therapeutic use, Adolescent ; Adult ; Animals ; Antigens, CD ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Nivolumab ; Lymphocyte Activation Gene 3 Protein
-
5دورية أكاديمية
المؤلفون: Parakh S; a Tumour Targeting Laboratory , Olivia Newton-John Cancer Research Institute , Melbourne , Australia.; b Department of Medical Oncology, Olivia Newton-John Cancer and Wellness Centre , Austin Health , Heidelberg, Melbourne , Australia.; c School of Cancer Medicine , La Trobe University , Melbourne , Australia., Parslow AC; a Tumour Targeting Laboratory , Olivia Newton-John Cancer Research Institute , Melbourne , Australia.; c School of Cancer Medicine , La Trobe University , Melbourne , Australia., Gan HK; a Tumour Targeting Laboratory , Olivia Newton-John Cancer Research Institute , Melbourne , Australia.; b Department of Medical Oncology, Olivia Newton-John Cancer and Wellness Centre , Austin Health , Heidelberg, Melbourne , Australia.; c School of Cancer Medicine , La Trobe University , Melbourne , Australia., Scott AM; a Tumour Targeting Laboratory , Olivia Newton-John Cancer Research Institute , Melbourne , Australia.; c School of Cancer Medicine , La Trobe University , Melbourne , Australia.; d Departmentof Molecular Imaging and Therapy , Austin Health , Melbourne , Australia.; e Department of Medicine , University of Melbourne , Melbourne , Australia.
المصدر: Expert opinion on drug delivery [Expert Opin Drug Deliv] 2016; Vol. 13 (3), pp. 401-19. Date of Electronic Publication: 2015 Dec 19.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review
بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 101228421 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7593 (Electronic) Linking ISSN: 17425247 NLM ISO Abbreviation: Expert Opin Drug Deliv Subsets: MEDLINE
-
6دورية أكاديمية
المؤلفون: Zhang J; a Division of Haematology-Oncology, Zhejiang Key Laboratory for Neonatal Diseases, Children's Hospital , Zhejiang University School of Medicine , Hangzhou , PR China., Shen D; a Division of Haematology-Oncology, Zhejiang Key Laboratory for Neonatal Diseases, Children's Hospital , Zhejiang University School of Medicine , Hangzhou , PR China., Jia M; a Division of Haematology-Oncology, Zhejiang Key Laboratory for Neonatal Diseases, Children's Hospital , Zhejiang University School of Medicine , Hangzhou , PR China., Zhao H; a Division of Haematology-Oncology, Zhejiang Key Laboratory for Neonatal Diseases, Children's Hospital , Zhejiang University School of Medicine , Hangzhou , PR China., Tang Y; a Division of Haematology-Oncology, Zhejiang Key Laboratory for Neonatal Diseases, Children's Hospital , Zhejiang University School of Medicine , Hangzhou , PR China.
المصدر: Journal of drug targeting [J Drug Target] 2018 Jan; Vol. 26 (1), pp. 55-65. Date of Electronic Publication: 2017 Jun 29.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312476 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2330 (Electronic) Linking ISSN: 10267158 NLM ISO Abbreviation: J Drug Target Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Monoclonal* , Liposomes*, Bridged Bicyclo Compounds, Heterocyclic/*pharmacology , Neoplastic Stem Cells/*drug effects, Animals ; Antigens, CD19 ; Basic-Leucine Zipper Transcription Factors ; Bridged Bicyclo Compounds, Heterocyclic/administration & dosage ; Cell Line, Tumor ; Cell Survival/drug effects ; Drug Delivery Systems ; Gene Expression Regulation, Neoplastic ; Humans ; Leukemia, B-Cell ; Mice
-
7دورية أكاديمية
المؤلفون: Respaud R; Université François Rabelais, EA6305 , Tours F-37032 , France., Vecellio L, Diot P, Heuzé-Vourc'h N
المصدر: Expert opinion on drug delivery [Expert Opin Drug Deliv] 2015 Jun; Vol. 12 (6), pp. 1027-39. Date of Electronic Publication: 2015 Jan 05.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review
بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 101228421 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7593 (Electronic) Linking ISSN: 17425247 NLM ISO Abbreviation: Expert Opin Drug Deliv Subsets: MEDLINE
-
8دورية أكاديمية
المؤلفون: Cui Y; a School of Pharmacy , Jining Medicinal College , Jining , China., Cui P; b Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, Tianjin , National Clinical Research Centre of Cancer, Tianjin Medical University Cancer Institute and Hospital , Tianjin , China., Chen B; c State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences , Peking University , Beijing , China.; d Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences , Peking University , Beijing , China., Li S; c State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences , Peking University , Beijing , China.; d Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences , Peking University , Beijing , China., Guan H; a School of Pharmacy , Jining Medicinal College , Jining , China.
المصدر: Drug development and industrial pharmacy [Drug Dev Ind Pharm] 2017 Apr; Vol. 43 (4), pp. 519-530. Date of Electronic Publication: 2017 Jan 22.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 7802620 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5762 (Electronic) Linking ISSN: 03639045 NLM ISO Abbreviation: Drug Dev Ind Pharm Subsets: MEDLINE
-
9دورية أكاديمية
المؤلفون: Steinhauser I; Institute of Pharmaceutical Technology, Biocenter of Goethe-University, Frankfurt, Germany., Langer K, Strebhardt K, Spänkuch B
المصدر: Journal of drug targeting [J Drug Target] 2009 Sep; Vol. 17 (8), pp. 627-37.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312476 Publication Model: Print Cited Medium: Internet ISSN: 1029-2330 (Electronic) Linking ISSN: 10267158 NLM ISO Abbreviation: J Drug Target Subsets: MEDLINE
مواضيع طبية MeSH: Drug Delivery Systems* , Nanoparticles*, Antibodies, Monoclonal/*administration & dosage , Antineoplastic Agents/*administration & dosage, Animals ; Antibodies, Monoclonal, Humanized ; Breast Neoplasms/drug therapy ; Breast Neoplasms/genetics ; Cell Cycle Proteins/genetics ; Cell Line, Tumor ; Drug Carriers/chemistry ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Mice ; Plasmids/administration & dosage ; Protein Serine-Threonine Kinases/genetics ; Proto-Oncogene Proteins/genetics ; RNA Interference ; RNA, Small Interfering/administration & dosage ; Receptor, ErbB-2/metabolism ; Serum Albumin/chemistry ; Trastuzumab ; Polo-Like Kinase 1
-
10دورية أكاديمية
المؤلفون: Sawant RM; Department of Pharmaceutical Sciences, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA 02115, USA., Cohen MB, Torchilin VP, Rokhlin OW
المصدر: Journal of drug targeting [J Drug Target] 2008 Aug; Vol. 16 (7), pp. 601-4.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312476 Publication Model: Print Cited Medium: Internet ISSN: 1029-2330 (Electronic) Linking ISSN: 10267158 NLM ISO Abbreviation: J Drug Target Subsets: MEDLINE
مواضيع طبية MeSH: Drug Carriers* , Drug Delivery Systems* , Liposomes*, Antibodies, Monoclonal/*administration & dosage , Antineoplastic Agents/*administration & dosage , Doxorubicin/*administration & dosage , Prostatic Neoplasms/*immunology, Antineoplastic Agents/therapeutic use ; Cell Line, Tumor ; Doxorubicin/therapeutic use ; Humans ; Male ; Particle Size